-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JIW5RzvmA7F/bqLmZN21R92IxzDVLWcGg3sLrxop3uK/giKOcJYCbKd+Gu8rgdlN zS4rQnkO8ZggQmMeMQAsQA== 0000000000-05-059464.txt : 20061005 0000000000-05-059464.hdr.sgml : 20061005 20051128085006 ACCESSION NUMBER: 0000000000-05-059464 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051128 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: LONG ISLAND PHYSICIAN HOLDINGS CORP CENTRAL INDEX KEY: 0001006868 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 113232989 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: ONE HUNTINGTON QUADRANGLE STREET 2: SUITE 4C 01 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 5164541900 MAIL ADDRESS: STREET 1: ONE HUNTINGTON QUADRANGLE STREET 2: SUITE 4C 01 CITY: MELVILLE STATE: NY ZIP: 11747 PUBLIC REFERENCE ACCESSION NUMBER: 0001144204-05-029699 LETTER 1 filename1.txt Via Facsimile and U.S. Mail Mail Stop 6010 November 23, 2005 Dr. Paul Kolker, M.D. President and Chief Executive Officer Long Island Physician Holdings Corporation One Huntington Quadrangle Suite 4C-01 Melville, NY 11747 Re: Long Island Physician Holdings Corporation Form 10-K for Fiscal Year Ended December 31, 2004 Filed September 23, 2005 File No. 000-27654 Dear Mr. Kolker: We have reviewed your response letter dated October 13, 2005 to our comment letter dated September 29, 2005 and have the following comment. Where indicated, we think you should revise your document in response to this comment. If you disagree, we will consider your explanation as to why our comment is inapplicable or a revision is unnecessary. Please be as detailed as necessary in your explanation. Please understand that the purpose of our review process is to assist you in your compliance with the applicable disclosure requirements and to enhance the overall disclosure in your filing. We look forward to working with you in these respects. We welcome any questions you may have about our comments or on any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. Form 10-K for Fiscal Year Ended December 31, 2004 Contingent Reserve Requirement, page F-11 1. Please include disclosure as provided in your response with regards to the consequences to your operations, cash flows and financial position that arise from not meeting the contingent reserve fund requirement or tell us why an amendment is not necessary. We believe it is important for the readers of your financial statements to understand that the NYSID and DOH could direct you to shutdown if they believed you were insolvent. In addition, please enhance your disclosure in MD&A under Capital Reserves and Liquidity on page 20 with regards to the consequences of not meeting the contingent reserve fund requirement. Please refer to Item 303 of Regulation S-K and FRC 501.02. * * * * As appropriate, please amend your filing and respond to this comment within 10 business days or tell us when you will provide us with a response. You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your response to our comment. Detailed cover letters greatly facilitate our review. Please file your letter on EDGAR under the form type label CORRESP. Please understand that we may have additional comments after reviewing your amendment and response to our comment. You may contact Sasha Parikh, Staff Accountant, at (202) 551- 3627 or Lisa Vanjoske, Assistant Chief Accountant, at (202) 551- 3614 if you have questions regarding the comments. In this regard, do not hesitate to contact me, at (202) 551-3679. Sincerely, Jim B. Rosenberg Senior Assistant Chief Accountant -----END PRIVACY-ENHANCED MESSAGE-----